Search
United States District Court Eastern District of California USA v Henry Benson, Roselle Cipriano Indictment Filed February 21, 2019 Read the document.
Read MoreUnited States District Court Eastern District of California USA v Jia Bei Zhu Criminal Complaint Filed October 18, 2023 Read the document.
Read MoreTests of the counterfeits showed that they were made of many substances, including acetaminophen, duloxetine, caffeine and methamphetamine. Overseas, authorities seized counterfeit pregabalin in Belfast. Pakistan recalled toxic cough syrup. Fake Xanax trafficker Ryan Farace got an additional sentence for money laundering. News about pill presses in five states.
Read MorePSM recently published contracts, some obtained via FOIA, with key vendors implementing Colorado’s and Florida’s Canadian drug importation plan. Read them here.
Read MoreFlorida’s October 20, 2023 SIP application is the second to last application before FDA approval. The final application was filed on November 16, 2023.
Read MoreAttachment D Cover Letter Biktarvy Descovy Dovato Genoya Juluca Odefsey Prezcobix Prezista Ravicti Rexulti Symtuza Tivicay Vraylar Xtandi
Read MoreHomeland Security seized over 1,800 pill presses in October and November 2023. The FDA warned Amazon not to sell supplements made with undeclared pharmaceuticals and issued another warning about toxic yellow oleander. More domestic and international news about counterfeit medicine.
Read MorePSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
Read MoreFDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. FDA is aware of five adverse events from this lot.
Read MoreThis is a reprint of an FDA Alert. 8th Avenue Pharmacy Issues Voluntary Nationwide Recall of Notoginseng Formula Special Gout Granule Due to the Presence of Hidden Drug Ingredients, Diclofenac and Dexamethasone When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product…
Read More